1Wang X;Lee SR;Arai K.Lipoprotein receptor-mediated induction of matrix metalloprot -einase by tissue plasminogen activato[J],2003(10).
2Zalewska T;Ziemka M;Sarnowska A.Involvenment of MMPs in delayed neuronal death after global ischemia,2002(02).
3Rosenberg GA;Navatil M;Borane F.Proteolytic cascade enzymes increase in focal cerebral ischemia in rat[J],1996.
4Montaner J;Alvarez-Sabin J;Molina C.Matrix metalloproteinase expression after human cardioembolic stroke:temporal profile and relation to neurological impair ment[J],2001(08).
6Gasehe Y;Fujimuro M;Morita Fujimuro Y.Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice:a possible role in blood.brain barrier dysfunction[J],1999(09).
7Montaner J;Rovira A;Moha CA.Phsmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions hyperacute stroke,2003.
8Montaner J;Alvarez-Sabin J;Mob a C.Matrix metalloproteinase expression after human cardioembolic stroke:temporal profile and relation to neuroiogical impairment[J],2001(12).
9Reynolds MA;Kirchick HJ;Dahlen JR.Early biomarkers of stroke[J],2003(10).
4Gasche Y, Fujimura M, Morita Fujimuro Y, et al. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice:a possible rote in blood-brain barrier dysfunction. J Cereb Blood Flow Metab, 1999, 19(9): 1020.
5Montaner J, Alvarez-Sabin J, Molina C, et al. Matrix metalloproteinttse expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke, 2001, 32(8) : 1759.
6Hamann GF. Unriddling the role of matrix metalloproteinases in human cerebral stroke. Stroke, 2003, 34(1): 40.
7Lima JE, Takayanagui OM, Garcia LV, et al. Use of neuron-specific enolase for assessing the severity and outcome of neurological disorders inpatients. Braz J Med Biol Res, 2004, 37(1):19.
8Hermmnn M, Ehrenreich H. Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring. Restor Neurol Neurosci, 2003, 21(3-4): 177.
9Montaner J, Alvarez-Sabin J, Molina CA, et al. Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke. Stroke, 2001, 32(12): 2762.
10Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke, 1998, 29(10): 2189.
2O' Rourke F, Dean N, Akhtar N, et al. Current and future concepts in stroke prevention[J]. CMAJ, 2004,170 :1123-1133.
3Cola C, Clementi E, Biondi-Zoccai G, et al. From carotid plaque bi ology to serologic markers of vulnerability to predict the risk of cerebrovascular events[J]. Acta Chir Belg, 2007,107: 129-142.
4Formato M, Farina M, Spirito R, et al. Evidence for a proin flammatory and proteolytic environment in plaques from endarterectomy segments of human carotid arteries[J]. Arterioseler Thromb Vasc Bioi,2004,24:129-135.
5Aadelmouttaleb I, Danchin H. C-reactive prctein and coronary artery disease: Additional evidence of the implication an inflamma tory process in acute coronary syndromes[J]. Am Heart J,1999, 349(9) :462-472.
7Gu Z, Cui J, Brown, et al. A highly specific inhibititor of matrix metallop roteinase 9 rescues laminin from proteolysis and neurous from apoptosis in transient focal cerebral ischemia[J]. J Neurosci, 2005,25(27) :6401-6408.
8O' Rourke F, Dean N, Akhtar N, etal. Current and future concepts in stroke prevention[J]. CMAJ, 2004, 170:1123-1133.
9Cola C, Clementi E, Biondi-Zoccai G, et al. From carotid plaque biology to serologic markers of vulnerability to predict the risk of ce- rebrovascular events[J]. Acta Chir Belg, 2007, 107:1 29-1 42.
10Aadelmouttaleb I, Danehin H. C-reactive prctein and coronary artery disease : Additional evidence of the implication an inflammatory process in acute curonary syndromes[J]. Am Heart J, 1999, 349(9): 462-472.
